Escobar Phone Scammer Pleads Guilty to Frauds Worth $1.3M

The creator of the infamous Escobar Phone, which rebranded Samsung Galaxy Folds at a significant loss, has pleaded guilty to wire and mail fraud and multiple counts of money laundering. Roberto Escobar, the brother of Pablo Escobar, founded Escobar Inc. to capitalize on his famous sibling’s name. The Escobar Fold 1, priced at $349, was … Read more

GOP Lawmaker Asks Justice Department to Probe Powell for Perjury

Republican Representative Anna Paulina Luna has referred a perjury claim against Federal Reserve Chair Jerome Powell to the US Department of Justice. In a July 19 letter, Luna accused Powell of lying under oath twice during Senate Banking Committee testimony on June 25 about the Fed’s $2.5 billion Washington headquarters project. The project has sparked … Read more

In-N-Out Burger CEO Denies Moving HQ from California

Lynsi Snyder, billionaire owner of In-N-Out Burger, has clarified that the company’s corporate headquarters will not be moving to Tennessee, but rather opening a new office there as part of its expansion plans. The move comes after initial reports suggested that Snyder would bring the headquarters to the Southeast state in search of lower taxes. … Read more

Ancient Viral DNA Reveals Hidden Code in Human Genome

Scientists have made a groundbreaking discovery about the human genome, revealing that ancient viral DNA may play a powerful role in regulating gene expression. A new study published in Science Advances suggests that certain sequences of DNA, known as transposable elements (TEs), were once thought to be “junk” but actually act like genetic switches. These … Read more

S&P 500 Reaches Record High Amid Nasdaq Slide

The S&P 500 reached a record high on July 22, 2025, while the Nasdaq Composite fell 0.4% due to AI stock selling. The Dow Jones Industrial Average rose 179 points, or 0.4%, and moved closer to its December record. Smallcap stocks posted strong gains in the rally. The tech-heavy index snapped its six-day streak of … Read more

COVID-19 Cases Rise in US Southeast and West Regions

COVID-19 activity in the US is increasing, particularly in the Southeast and West regions. The Centers for Disease Control and Prevention (CDC) reports a rise in early indicators, including emergency department visits and test positivity rates. Emergency department visits rose 10.9% from the previous week, with children under 4 experiencing greater increases. Test positivity rates … Read more

Lions Training Camp Takeaways: Gibbs Poised for Bigger Role

The Detroit Lions’ training camp is underway, and with it comes a new era of opportunity under the guidance of offensive coordinator John Morton. One player who’s likely to see increased action is third-year running back Jahmyr Gibbs. The team developed him further in the spring by having him work at various positions and through … Read more

Varnish Cache Server Returns Error 54113 and Access Denied

A technical issue with the Varnish cache server has caused an error (Error 54113) and access denial for users. The issue is related to a specific cache entry, ID cache-ewr-kewr1740067-EWR, which has been locked out due to a timestamp discrepancy. The affected system uses the Varnish cache server for its caching needs. Source: https://www.mlb.com/news/prospects-dealt-at-the-2025-trade-deadline

Lions Training Camp Opens with New Faces and Uncertainty

The Detroit Lions’ 2025 training camp has begun, marking a new chapter for the team as they look to build on last season’s success. With several key coaches and players departing, the road ahead is uncertain. However, head coach Dan Campbell remains focused on winning the franchise’s first Lombardi Trophy. The Lions have lost coordinators … Read more

Sarepta Halt Elevidys Shipments Amid Rare Gene Therapy Deaths

US-based gene therapy company Sarepta Therapeutics will pause shipments of its Elevidys treatment for rare muscle disorders after two teenage boys died from liver failure following the treatment. The US FDA had asked the company to halt the shipments earlier this week, amid safety concerns over a third patient’s death who received an experimental therapy. … Read more